The main objective of this INFRAFRONTIER open call is
to facilitate access for the wider biomedical research community to the unique infrastructure and scientific expertise of the participating INFRAFRONTIER partners
to deliver novel mouse lines that will advance knowledge of human disease and will be of widespread use in biomedical science.
Recent advances in genome editing technology will be used to develop new mouse models of human disease. INFRAFRONTIER will provide open access to all newly developed disease models through the European Mouse Mutant Archive (EMMA).
Access to this free-of-charge-service will be granted on the basis of the applicant’s research plans and the potential impact of the proposed novel mouse line on the wider biomedical research community.
This Trans-national Access call of the INFRAFRONTIER2020 project supports a total of 12 precision mouse model development projects. A complementary call provides support for 3 customised rat model development projects.